Author: Sharief M.K.
Publisher: Adis International
ISSN: 1173-2563
Source: Clinical Drug Investigation, Vol.23, Iss.9, 2003-01, pp. : 551-559
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Interferon- Therapy in Multiple Sclerosis: Evidence for a Clinically Relevant Dose Response
By Goodin D.S.
Drugs, Vol. 61, Iss. 12, 2001-01 ,pp. :
Interferon-β-1b: A Review of its Use in Multiple Sclerosis
CNS Drugs, Vol. 25, Iss. 1, 2011-01 ,pp. :